Status:
COMPLETED
Investigation of Clot in Ischemic Stroke and Hematoma Evacuation
Lead Sponsor:
Penumbra Inc.
Conditions:
Ischemic Stroke
Intracranial Hematoma
Eligibility:
All Genders
18+ years
Brief Summary
The aim of the study is to collect and analyze specimen from ischemic stroke patients undergoing thrombectomy procedures and from patients undergoing minimally invasive surgery for intracranial hemato...
Eligibility Criteria
Inclusion
- ≥ 18 Years of Age
- Frontline treatment with: Penumbra System for ischemic stroke patients eligible for mechanical thrombectomy or Artemis Neuro Evacuation device for intracranial hematoma evacuation in patients eligible for minimally invasive surgery (MIS)
- Extracted thrombus/embolus
- Informed consent is obtained from either the patient or legally authorized representative (LAR)
Exclusion
- Pregnancy or positive pregnancy test according to site routine practice (only required for women of child bearing potential; serum or urine acceptable)
- Currently participating in an investigational drug or device clinical trial that may confound the ability to capture clot and/or influence clot composition. Patients in observational, natural history, and/or epidemiological studies not involving intervention are eligible
Key Trial Info
Start Date :
February 16 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 3 2022
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04693767
Start Date
February 16 2021
End Date
August 3 2022
Last Update
October 23 2024
Active Locations (27)
Enter a location and click search to find clinical trials sorted by distance.
1
Banner Desert Medical Center
Mesa, Arizona, United States, 85202
2
Banner University Medical Center - Phoenix
Phoenix, Arizona, United States, 85006
3
Christiana Care
Newark, Delaware, United States, 19713
4
George Washington University
Washington D.C., District of Columbia, United States, 20037